Bladder Cancer - Results from #540

REVIEW UroToday

Differentiating Reactive Lymph Nodes from Bladder Cancer Lymph Node Metastasis Using Dual Time Point 18F-FDG PET/CT Imaging - Expert Commentary March 6, 2024

Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics. March 6, 2024

The Value of Dual Time Point 18F-FDG PET/CT Imaging in Differentiating Lymph Node Metastasis From Reactive Hyperplasia in Bladder Urothelial Carcinoma. March 6, 2024

Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience. March 6, 2024

Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center Retrospective Study From 2004 to 2021. March 6, 2024

Survivin as a potential biomarker in the diagnosis of bladder cancer: A systematic review and meta-analysis. March 5, 2024

A combinatorial genetic strategy for exploring complex genotype-phenotype associations in cancer. March 5, 2024

Emerging Trends in AI and Radiomics for Bladder, Kidney, and Prostate Cancer: A Critical Review. March 5, 2024

Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology. March 4, 2024

The role of neoadjuvant chemotherapy for patients with variant histology muscle invasive bladder cancer undergoing robotic cystectomy: Data from the International Robotic Cystectomy Consortium. March 4, 2024

The urinary microbiome associated with bladder cancer. March 4, 2024

Functional and oncologic outcomes of prostate capsule-sparing radical cystectomy: A systematic review and meta-analysis. March 1, 2024

Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy. March 1, 2024

DaBlaCa-17: nationwide observational study in Denmark on survival before and after implementation of neoadjuvant chemotherapy prior to cystectomy for muscle-invasive bladder cancer. February 29, 2024

Impact of bladder cancer family history on the prognosis of patients with Non-Muscle Invasive bladder cancer Treated with Bacillus Calmette-Guerin (BCG). February 29, 2024

A novel grading approach predicts worse outcomes in stage pT1 non-muscle-invasive bladder cancer. February 28, 2024

Lessons from a population-based bladder cancer registry: exploring why survival is not improving. February 28, 2024

BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer. February 27, 2024

Urine-Based Biomarker Test Uromonitor® in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of Diagnostic Test Performance. February 27, 2024

Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer. February 27, 2024

Page 28 of 517